Atrial Fibrillation
Saturday, December 14th, 2013
J Am Heart Assoc.: November 25, 2013 Background Limited data exist on the economic implications of stroke among patients with atrial fibrillation (AF). This study assesses the impact of AF on healthcare costs associated with ischemic stroke (IS), hemorrhagic stroke (HS), or transient ischemic attack (TIA). Methods and Results A retrospective analysis of MarketScan claims data (2005‐2011) for […]
Clinical Trials
Saturday, December 14th, 2013
STROKEAHA: December 5, 2013 Background and Purpose—Early poststroke aphasia rehabilitation effects and their functional MRI (fMRI) correlates were investigated in a pilot, controlled longitudinal study. Methods—Twelve patients with mild/moderate aphasia (8 Broca, 3 anomic, and 1 Wernicke) were randomly assigned to daily language rehabilitation for 2 weeks (starting 2.2 [mean] days poststroke) or no rehabilitation. The […]
Clinical Trials
Saturday, December 14th, 2013
STROKEAHA: November 26, 2013 Background and Purpose—Rapid, accurate, and reliable identification of the computed tomography angiography spot sign is required to identify patients with intracerebral hemorrhage for trials of acute hemostatic therapy. We sought to assess the accuracy and interobserver agreement for spot sign identification. Methods—A total of 131 neurology, emergency medicine, and neuroradiology staff and […]
Clinical Trials
Saturday, December 14th, 2013
STROKEAHA: November 19, 2013 Early Short-Term Dual Antiplatelet Treatment for Stroke Prevention The Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) trial tested the effect of early dual antiplatelet treatment for the prevention of secondary stroke within the first 90 days following a qualifying transient ischemic attack (TIA) or minor stroke in 5170 […]
Clinical Trials
Saturday, December 14th, 2013
STROKEAHA: November 12, 2013 Is it appropriate to enroll into a clinical trial (and hence randomize to either medical or endovascular therapy) a 45-year-old patient who presents within 3 hours of onset of disabling symptoms resulting from a left M1 occlusion? This is the question many of us have faced in the course of the past […]
Clinical Trials
Saturday, December 14th, 2013
The Lancet: October 26, 2013 Background Early results of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14·7%) of 224 patients in the stenting group and 13 (5·8%) of 227 patients in the medical group had died or had a stroke (percentages are […]
Therapies
Saturday, December 14th, 2013
American Heart Association: December 5, 2013 Background and Purpose—Stroke mortality has been declining since the early 20th century. The reasons for this are not completely understood, although the decline is welcome. As a result of recent striking and more accelerated decreases in stroke mortality, stroke has fallen from the third to the fourth leading cause of […]
Therapies
Saturday, December 14th, 2013
AHA: 12/5/13 Cardiovascular diseases (CVDs) are a major source of morbidity and mortality worldwide. Despite a decline of ≈30% over the past decade, heart disease remains the leading killer of Americans.1 For rare and familial forms of CVD, we are increasingly recognizing single-gene mutations that impart relatively large effects on individual phenotype. Examples include inherited […]
Therapies
Saturday, December 14th, 2013
STROKEAHA: November 26, 2013 Background and Purpose—Studies have suggested that the early excess risk of stroke in coronary artery bypass grafting (CABG) may be compensated for by a slow but progressive catch-up phenomenon in patients undergoing percutaneous coronary intervention (PCI). We therefore undertook this analysis to compare the temporal stroke risk between PCI and CABG in […]
Therapies
Saturday, December 14th, 2013
STROKEAHA: November 5, 2013 Background and Purpose—Kinesthesia, the sense of body motion, is essential to proper control and execution of movement. Despite its importance for activities of daily living, no current clinical measures can objectively measure kinesthetic deficits. The goal of this study was to use robotic technology to quantify prevalence and severity of kinesthetic deficits […]
